{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:49:39Z","timestamp":1782514179464,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clineuro.2026.109430","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:01:30Z","timestamp":1776985290000},"page":"109430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development and expert refinement of a stratified framework for progression independent of relapse activity (PIRA) in multiple sclerosis"],"prefix":"10.1016","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-7454","authenticated-orcid":false,"given":"Eman","family":"Hamdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farouk","family":"Talaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike Cosima","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Abousteit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-4766","authenticated-orcid":false,"given":"Salma S.","family":"Almashad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6842-5609","authenticated-orcid":false,"given":"Maya","family":"Zeineddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh M.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Carnero Contentti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Gaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magd","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9375-3110","authenticated-orcid":false,"given":"Sandra","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4706-4637","authenticated-orcid":false,"given":"Nikolaos","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basem Hamdy","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevin Mohieldin","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Zamzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Krupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8490-3834","authenticated-orcid":false,"given":"Amira","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shady Safwat","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged Abdel","family":"Naseer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed I.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Abel","family":"Galeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Elmenshawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2380-8152","authenticated-orcid":false,"given":"Sara","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clineuro.2026.109430_bib1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/ijms26030884","article-title":"A window into new insights on progression independent of relapse activity in multiple sclerosis: role of therapies and current perspective","volume":"26","author":"Guerra","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.clineuro.2026.109430_bib2","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1093\/brain\/awac111","article-title":"Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study","volume":"145","author":"Portaccio","year":"2022","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.clineuro.2026.109430_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon Beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"10127","key":"10.1016\/j.clineuro.2026.109430_bib4","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","article-title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clineuro.2026.109430_bib5","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of Relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109430_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10040868","article-title":"Assessment of disability progression independent of relapse and brain MRI activity in patients with multiple sclerosis in poland","volume":"10","author":"Kapica-Topczewska","year":"2021","journal-title":"J. Clin. Med"},{"issue":"2","key":"10.1016\/j.clineuro.2026.109430_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamaneurol.2022.4655","article-title":"Association of early progression independent of relapse activity with long-term disability after a first demyelinating event in multiple sclerosis","volume":"80","author":"Tur","year":"2023","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109430_bib8","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209444","article-title":"Using the progression independent of relapse activity framework to unveil the pathobiological foundations of multiple sclerosis","volume":"103","author":"Ciccarelli","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2026.109430_bib9","series-title":"Ann Neurol","article-title":"Smouldering-associated worsening in multiple sclerosis: an international consensus statement on definition, biology, clinical implications, and future directions","author":"Scalfari","year":"2024"},{"key":"10.1016\/j.clineuro.2026.109430_bib10","article-title":"Defining progression independent of relapse activity (PIRA) in adult patients with relapsing multiple sclerosis: a systematic review\u2606","volume":"78","author":"Sharrad","year":"2023"},{"issue":"11","key":"10.1016\/j.clineuro.2026.109430_bib11","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamaneurol.2023.3331","article-title":"Harmonizing definitions for progression independent of relapse activity in multiple sclerosis","volume":"80","author":"M\u00fcller","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2026.109430_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.608491","article-title":"Deciphering multiple sclerosis progression","volume":"12","author":"Meca-Lallana","year":"2021","journal-title":"Front Neurol."},{"key":"10.1016\/j.clineuro.2026.109430_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103144","article-title":"Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability","volume":"54","author":"Cohen","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109430_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/1352458516638941","article-title":"The EDSS-plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis","volume":"23","author":"Cadavid","year":"2017","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.clineuro.2026.109430_bib15","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s40120-023-00549-7","article-title":"No evidence of disease activity (NEDA) as a clinical assessment tool for multiple sclerosis: clinician and patient perspectives [narrative review]","volume":"12","author":"Newsome","year":"2023","journal-title":"Neurol. Ther."},{"issue":"13","key":"10.1016\/j.clineuro.2026.109430_bib16","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1177\/1352458518809326","article-title":"International consensus on quality standards for brain health-focused care in multiple sclerosis","volume":"25","author":"Hobart","year":"2019","journal-title":"Mult. Scler. J."},{"issue":"10","key":"10.1016\/j.clineuro.2026.109430_bib17","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1093\/brain\/awab241","article-title":"The potential of serum neurofilament as biomarker for multiple sclerosis","volume":"144","author":"Bittner","year":"2021","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.clineuro.2026.109430_bib18","doi-asserted-by":"crossref","first-page":"A25.2","DOI":"10.1136\/jnnp-2018-ANZAN.60","article-title":"061 ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis (RMS) (ENCORE)","volume":"89","author":"Kappos","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2026.109430_bib19","unstructured":"Medicines Agency E. Committee for Medicinal Products for Human Use (CHMP) Draft qualification opinion of Multiple sclerosis clinical 4 outcome assessment (MSCOA) 5 6. Published online 2019. Accessed February 4, 2022. \u3008www.ema.europa.eu\/contact\u3009."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109430_bib20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/1352458506069926","article-title":"Subtle upper limb impairment in asymptomatic multiple sclerosis subjects","volume":"13","author":"Solaro","year":"2007","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109430_bib21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/diagnostics11040584","article-title":"Gait pattern in people with multiple sclerosis: a systematic review","volume":"11","author":"Coca-Tapia","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.clineuro.2026.109430_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fnbot.2022.920118","article-title":"Upper limb sensory-motor control during exposure to different mechanical environments in multiple sclerosis subjects with no clinical disability","volume":"16","author":"Pierella","year":"2022","journal-title":"Front Neurorobot"},{"key":"10.1016\/j.clineuro.2026.109430_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.msard.2019.05.019","article-title":"Review: patient-reported outcomes in multiple sclerosis care","volume":"33","author":"D\u2019Amico","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109430_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5152\/npa.2015.8714","article-title":"Correlation of fatigue with depression, disability level and quality of life in patients with multiple sclerosis","volume":"52","author":"Kaya Ayg\u00fcno\u011flu","year":"2015","journal-title":"Noro Psikiyatr Ars"},{"issue":"2","key":"10.1016\/j.clineuro.2026.109430_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1179\/174313209X455664","article-title":"Neuropsychiatric manifestations in multiple sclerosis: correlation of fatigue and depression with disease progression","volume":"32","author":"Kale","year":"2010","journal-title":"Neurol. Res"},{"key":"10.1016\/j.clineuro.2026.109430_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.msard.2018.05.013","article-title":"Depression is a predictor for balance in people with multiple sclerosis","volume":"24","author":"Alghwiri","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.clineuro.2026.109430_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103757","article-title":"The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: progresses and open questions","volume":"61","author":"Zaratin","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.clineuro.2026.109430_bib28","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1007\/s00415-024-12448-4","article-title":"Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression","volume":"271","author":"Portaccio","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2026.109430_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103927","article-title":"Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies","volume":"63","author":"Masanneck","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.clineuro.2026.109430_bib30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jamaneurol.2022.1025","article-title":"Association of brain atrophy with disease progression independent of relapse activity in patients with relapsing multiple sclerosis","volume":"79","author":"Cagol","year":"2022","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2026.109430_bib31","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210004","article-title":"Associations between paramagnetic rim lesion evolution and clinical and radiologic disease progression in persons with multiple sclerosis","volume":"103","author":"Reeves","year":"2024","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.clineuro.2026.109430_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14124114","article-title":"The role of MRI lesions in identifying secondary progressive multiple sclerosis: a comprehensive review","volume":"14","author":"Anic\u0103i","year":"2025","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109430_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ncl.2010.12.011","article-title":"Advanced MRI in multiple sclerosis: current status and future challenges","volume":"29","author":"Fox","year":"2011","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.clineuro.2026.109430_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241229325","article-title":"Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?","volume":"17","author":"Hoffmann","year":"2024","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"13","key":"10.1016\/j.clineuro.2026.109430_bib35","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1177\/1352458517739990","article-title":"The NAIMS cooperative pilot project: design, implementation and future directions","volume":"24","author":"Oh","year":"2018","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109430_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jamaneurol.2024.0017","article-title":"Emerging cerebrospinal fluid biomarkers of disease activity and progression in multiple sclerosis","volume":"81","author":"Cross","year":"2024","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109430_bib37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1148\/radiol.12112680","article-title":"Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: a cross-sectional 23Na MR imaging study","volume":"264","author":"Zaaraoui","year":"2012","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.clineuro.2026.109430_bib38","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/brain\/awab088","article-title":"Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging","volume":"144","author":"Rahmanzadeh","year":"2021","journal-title":"Brain"},{"issue":"3_","key":"10.1016\/j.clineuro.2026.109430_bib39","first-page":"4","article-title":"ECTRIMS 2024 \u2013 oral presentations - synaptic density in multiple sclerosis: an in vivo study using [11C]UCB-J-PET imaging","volume":"30","author":"Luoma","year":"2024","journal-title":"Mult. Scler. J."},{"issue":"16","key":"10.1016\/j.clineuro.2026.109430_bib40","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000295995.46586.ae","article-title":"Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis","volume":"69","author":"Gordon-Lipkin","year":"2007","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.clineuro.2026.109430_bib41","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1167\/iovs.12-10362","article-title":"Progressive degeneration of the retinal nerve fiber layer in patients with multiple sclerosis","volume":"53","author":"Herrero","year":"2012","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109430_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1474-4422(04)00964-0","article-title":"Biological markers in CSF and blood for axonal degeneration in multiple sclerosis","volume":"4","author":"Teunissen","year":"2005","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109430_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/00368504251390710","article-title":"Multiple sclerosis: glial cell activation \u2013 Biomarker advances and their translational significance","volume":"108","author":"Zeng","year":"2025","journal-title":"Sci. Prog."},{"issue":"21","key":"10.1016\/j.clineuro.2026.109430_bib44","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1212\/WNL.0000000000002702","article-title":"Brain reserve against physical disability progression over 5 years in multiple sclerosis","volume":"86","author":"Sumowski","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2026.109430_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/307175","article-title":"Neural plasticity in multiple sclerosis: the functional and molecular background","volume":"2015","author":"Ksiazek-Winiarek","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.clineuro.2026.109430_bib46","doi-asserted-by":"crossref","first-page":"308","DOI":"10.5114\/pjr\/188633","article-title":"Brain neuroplasticity in multiple sclerosis patients in functional magnetic resonance imaging. Part 1: comparison with healthy volunteers","volume":"89","author":"Wachowski","year":"2024","journal-title":"Pol. J. Radio."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109430_bib47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: how to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J. Method."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109430_bib48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109430_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"key":"10.1016\/j.clineuro.2026.109430_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211066751","article-title":"Smouldering multiple sclerosis: the \u201creal MS.\u201d","volume":"15","author":"Giovannoni","year":"2022","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"12","key":"10.1016\/j.clineuro.2026.109430_bib51","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","article-title":"Association of chronic active multiple sclerosis lesions with disability in vivo","volume":"76","author":"Absinta","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2026.109430_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105802","article-title":"Uncovering a bias in estimated treatment effects on PIRA in multiple sclerosis clinical trials","volume":"117","author":"Montobbio","year":"2025","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.clineuro.2026.109430_bib53","doi-asserted-by":"crossref","DOI":"10.2196\/25748","article-title":"Assessing cognitive function in multiple sclerosis with digital tools: observational study","volume":"23","author":"Hsu","year":"2021","journal-title":"J. Med Internet Res"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109430_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726001228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726001228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:30:10Z","timestamp":1782513010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846726001228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":54,"alternative-id":["S0303846726001228"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109430","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and expert refinement of a stratified framework for progression independent of relapse activity (PIRA) in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109430"}}